Loading...
Biosimilars entering the clinic without animal studies: A paradigm shift in the European Union
The concept of biosimilars has spread from Europe to other regions throughout the world, and many regions have drafted regulatory guidelines for their development. Recently, a paradigm shift in regulatory thinking on the non-clinical development of biosimilars has emerged in Europe: In vivo testing...
Na minha lista:
| Udgivet i: | MAbs |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622966/ https://ncbi.nlm.nih.gov/pubmed/25517301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.29848 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|